Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of key cancer, heart and kidney disease drugs, prompting…

Image source: The Motley Fool.DATEMonday, Nov. 3, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Helen TorleySenior…

AstraZeneca shareholders approved a direct listing of the drugmakers shares on the New York Stock Exchange on Monday, giving it…

AstraZeneca shareholders approved a direct listing of the drugmakers shares on the New York Stock Exchange on Monday, giving it…

3 November 2025Result of General Meeting held on 3 November 2025AstraZeneca PLC (the Company) announced that at the General Meeting…

When AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) reports third-quarter results next Thursday, 6 November, with investors and analysts will be keen to hear about...…

Astrazeneca (AZN) closed at $82.61 in the latest trading session, marking a -1.72% move from the prior day.…

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is looking more marathon runner than sprinter these days. The pharmaceuticals giant has spent years building…

IRW-PRESS: ACCESS Newswire: Führende Fortune-500-Unternehmen berichten im Rahmen einer OMP-Konferenz über KI-Kompetenzen zur Stärkung der LieferketteBranchenriesen wie AstraZeneca, Johnson &…

AstraZeneca, RTX, and Applied Materials stand out in todays Zacks Research Daily with strong performance drivers and key growth catalysts.…

In the latest trading session, Astrazeneca (AZN) closed at $84.69, marking a +1.03% move from the previous day.…

With the administration’s aggressive tactics, pharmaceutical companies cannot avoid this reckoning, but they can shape how it unfolds.…

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) investors might want to take a deep breath. Deutsche Bank has turned bearish on the UK…

AstraZeneca secures a three-year tariff break after striking a landmark U.S. deal to cut drug prices and expand its domestic…

A lively start to the week, with Lloyds digging deeper into its pockets, AstraZeneca bowing to US price pressures, and…

Following AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) agreement with the US government on most favoured nation drug pricing at the end of last week,...…

AstraZeneca (AZN) trotzt dem Gegenwind in der Pharmabranche. Mit einem historischen Preisdeal in den USA, milliardenschweren Investitionen in heimische US-Produktion…

AstraZeneca has announced an agreement with the Trump administration to dramatically reduce prescription medicine costs for American patients while preserving…

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has become the second giant drugmaker to announce a drug pricing deal with the US government, after Pfizers…

FTSE 100 up 6 points to 9,434 Lloyds rises after confirming extra provisions AstraZeneca little moved after US drug pricing…